TAG:
human genome
December 23, 2013 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XX, No. 17 – December 23, 2013 Issue
Saudi Arabia is the second country to embark on the goal of sequencing 100,000 human genomes. Earlier this month, the Saudi Human Genome Program was announced. Funding for the program, expected to take five years, will be provided by the Saudi Arabian national science agency. The fir…
May 06, 2013 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XX No. 6 – May 6, 2013 Issue
Much is happening in the anatomic pathology market in the Pacific Northwest. PAML, LLC (Spokane, Washington), and CellNetix (Seattle, Washington) finally executed the agreement whereby PAML made an equity investment in CellNetix. Now, the two lab companies will collaborate on developing…
Finding Lab Growth Opportunities Amid the Gloom
By R. Lewis Dark | From the Volume XIX No. 18 – December 31, 2012 Issue
IN MANY WAYS, THE TRADITIONAL BUSINESS MODELS for laboratory testing services are proving deficient in the face of a swiftly-evolving healthcare system. I suspect that none of us fully understand how many laboratory organizations are already under extreme financial stress. We intuitively understand …
April 23, 2012 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XIX No. 6 – April 23, 2012 Issue
“Innovator of the Year” honors were recently bestowed on Robin Felder, Ph.D., who is Professor of Pathology and Associate Director of Clinical Chemistry at the University of Virginia School of Medicine in Charlottesville. Felder was selected as the winner of the 2012 Edlich-Hen…
Exome Sequencing Next “Big Thing” for Diagnosis
By Joseph Burns | From the Volume XIX No. 5 – April 2, 2012 Issue
CEO SUMMARY: For disease diagnostics, exome sequencing is not yet routine, but geneticists are getting close. Using this technology, researchers read those parts of the human genome where about 85% of disease-causing mutations reside. By looking only at the regions that encode proteins—…
April 2, 2012 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XIX No. 5 – April 2, 2012 Issue
Like a tenacious bulldog, Roche Holding AG continues its determined effort to acquire Illumina, Inc., the company that makes gene sequencing systems. Last week, Roche increased its offer from $44.50 per share to $51 per share for Illumina stock. That raises the price…
Considering Full versus Partial Adoption of Digital Pathology
By Robert Michel | From the Volume XVIII No. 17 – December 19, 2011 Issue
CEO SUMMARY: Digital pathology is considered to be one of the more disruptive technologies now finding acceptance in anatomic pathology. Since founding Aperio Technologies, Inc., of Vista, California, in 1999, President Dirk G. Soenksen, M.S., M.B.A., has been in the forefront of this imp…
How Digital Pathology Helps Pathologists Deliver Added Value
By Robert Michel | From the Volume XVIII No. 12 – September 6, 2011 Issue
“Pathologists have the opportunity to take on a new clinical role as the integrator of all that digital pathology information, in combination with the patient’s other clinical data collected from a wide variety of sources.” —Dirk G. Soenksen, M.S., M.B.A., Founder…
May 23, 2011 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XVIII No. 7 – May 23, 2011 Issue
The first sequencing of the whole human genome back in 2000 unleashed a tidal wave of research and development. Recently, Fast Company Magazine quantified the dollar impact of the Human Genome Project and now says it totals $800 billion! Their reporter communicates this so succinctly that TH…
Our Top Ten Lab Stories Highlight Major Changes
By Robert Michel | From the Volume XVII No. 17 – December 6, 2010 Issue
CEO SUMMARY: What makes 2010 a watershed year for the laboratory testing industry is enactment of the 2,700-page Patient Protection and Affordable Care Act (PPACA). Even if parts of this bill are repealed, the remaining parts of the massive legislation will trigger major changes …
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized